Dapagliflozin Sitagliptin tablets combine SGLT2 and DPP-4 inhibition to effectively manage type 2 diabetes. This dual-action therapy improves glycemic control, promotes weight loss, lowers cardiovascular risk, and enhances insulin sensitivity, offering comprehensive metabolic support with a reduced risk of hypoglycemia.
| Dosage | 5/50 mg |
|---|---|
| Pack Size | 1*10 |
| Form | Tablet |
| Manufacturer | Zydus |
| Storage Conditions | Ambient Temperature |
| Shelf Life | 2 Years |
Trade Marks displayed in compliance with provisions of: provisions Trademark Act, 1999 u/s 30 and 30 (1) of “Fair use”
GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of PANTIN-D CAP – Domperidone+ Pantoprazole which is also known as PANTIN and Manufactured by Hetro pharmaceutical. It is available in strength of (30mg) + (40mg) per ml.
PANTIN-D CAP – Domperidone+ Pantoprazole is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.
Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of “Fair use”
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required in the act.
